scientifyRESEARCH
research funding database

RESEARCH FUNDING

Real-World Clinical Outcomes Among Adult and Adolescent Patients with Severe Alopecia Areata Receiving Ritlecitinib in China

Share this post

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.
Logo of scientifyRESEARCH + logo of Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.

The Real-World Clinical Outcomes Among Adult and Adolescent Patients with Severe Alopecia Areata Receiving Ritlecitinib in China research funding from Pfizer seeks to estimate real-world effectiveness of ritlecitinib for adult and adolescent patients with severe alopecia areata (AA). Research projects to be supported should be focused on the effectiveness of ritlecitinib in real-world clinical settings in China.

Applications are open to researchers at research institutions in China. The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.

Applicants may apply for up to 45,000 USD (including 28% indirect costs).

Applications are due on August 5, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
scientifyRESEARCH
monthly funding newsletter

unsubscribe at any time